Handelsbanken Fonder AB - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$560
-22.1%
34,646
+100.0%
0.00%
-25.0%
Q2 2023$719
-23.0%
17,323
+11.6%
0.00%
-20.0%
Q1 2023$934
-18.0%
15,5230.0%0.01%
-28.6%
Q4 2022$1,139
-99.9%
15,523
+2.6%
0.01%
-12.5%
Q3 2022$1,149,000
+9.3%
15,1230.0%0.01%
+14.3%
Q2 2022$1,051,000
-10.2%
15,123
+7.1%
0.01%0.0%
Q1 2022$1,170,000
-3.4%
14,123
-12.4%
0.01%
+16.7%
Q4 2021$1,211,000
-65.3%
16,123
+2.5%
0.01%
-66.7%
Q2 2021$3,488,000
+26.6%
15,723
-1.3%
0.02%
+5.9%
Q4 2020$2,755,00015,9230.02%
Other shareholders
NOVOCURE LTD shareholders Q1 2021
NameSharesValueWeighting ↓
StepStone Group LP 115,479$7,302,00011.05%
HARTLINE INVESTMENT CORP/ 335,585$21,219,0005.07%
Darsana Capital Partners LP 1,500,000$94,845,0003.08%
Rhenman & Partners Asset Management AB 365,899$23,136,0002.55%
COURAGE CAPITAL MANAGEMENT LLC 20,000$1,265,0002.15%
Taylor Frigon Capital Management LLC 46,599$2,946,0002.04%
Granite Investment Partners, LLC 411,659$26,029,0001.40%
Nicholas Investment Partners, LP 146,106$9,238,0000.85%
Baillie Gifford 8,829,449$558,287,0000.59%
Cortina Asset Management, LLC 141,352$8,938,0000.55%
View complete list of NOVOCURE LTD shareholders